Short Interest in Abrdn Life Sciences Investors (NYSE:HQL) Grows By 46.5%

Abrdn Life Sciences Investors (NYSE:HQL - Get Free Report) was the target of a significant increase in short interest in April. As of April 15th, there was short interest totalling 111,800 shares, an increase of 46.5% from the March 31st total of 76,300 shares. Approximately 0.5% of the company's shares are sold short. Based on an average trading volume of 132,500 shares, the short-interest ratio is presently 0.8 days.

Abrdn Life Sciences Investors Trading Down 1.8 %

Shares of Abrdn Life Sciences Investors stock traded down $0.22 on Wednesday, hitting $12.09. 58,093 shares of the company's stock were exchanged, compared to its average volume of 127,617. The company has a 50-day simple moving average of $12.46 and a 200-day simple moving average of $13.49. Abrdn Life Sciences Investors has a 1 year low of $10.55 and a 1 year high of $15.90.

Abrdn Life Sciences Investors Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Friday, February 21st were given a dividend of $0.47 per share. The ex-dividend date of this dividend was Friday, February 21st. This represents a $1.88 dividend on an annualized basis and a yield of 15.55%.

Insider Activity at Abrdn Life Sciences Investors

In other news, major shareholder Saba Capital Management, L.P. sold 36,536 shares of the company's stock in a transaction dated Wednesday, February 12th. The shares were sold at an average price of $13.75, for a total value of $502,370.00. Following the sale, the insider now directly owns 3,276,181 shares of the company's stock, valued at $45,047,488.75. This represents a 1.10 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders have sold a total of 251,959 shares of company stock worth $3,205,206 over the last quarter. Corporate insiders own 10.06% of the company's stock.

Institutional Trading of Abrdn Life Sciences Investors

A number of institutional investors have recently bought and sold shares of HQL. Commonwealth Equity Services LLC lifted its holdings in shares of Abrdn Life Sciences Investors by 3.2% in the 4th quarter. Commonwealth Equity Services LLC now owns 30,119 shares of the company's stock worth $395,000 after acquiring an additional 933 shares during the last quarter. Stratos Wealth Partners LTD. lifted its position in shares of Abrdn Life Sciences Investors by 7.4% during the first quarter. Stratos Wealth Partners LTD. now owns 14,176 shares of the company's stock worth $180,000 after purchasing an additional 971 shares during the last quarter. Kingsview Wealth Management LLC boosted its position in Abrdn Life Sciences Investors by 3.1% in the 1st quarter. Kingsview Wealth Management LLC now owns 35,743 shares of the company's stock valued at $454,000 after buying an additional 1,060 shares during the period. Private Advisor Group LLC boosted its holdings in shares of Abrdn Life Sciences Investors by 5.0% in the first quarter. Private Advisor Group LLC now owns 23,075 shares of the company's stock valued at $293,000 after purchasing an additional 1,097 shares during the period. Finally, 180 Wealth Advisors LLC lifted its position in shares of Abrdn Life Sciences Investors by 0.9% in the 1st quarter. 180 Wealth Advisors LLC now owns 136,122 shares of the company's stock worth $1,727,000 after purchasing an additional 1,247 shares during the period. 32.21% of the stock is currently owned by institutional investors.

About Abrdn Life Sciences Investors

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.